Aug 2 (Reuters) - Medical device company CryoCor Inc. said the U.S. Food and Drug Administration has granted pre-market approval for its device for the treatment of right atrial flutter, or abnormal ...
Stockhead on MSN
Health Check: Imricor shares soar on the heart device play’s second FDA clearance this month
Two weeks after giving the nod to Imricor's novel ablation catheter, the FDA has cleared the company's overriding 'dashboard' ...
June 28 (Reuters) - Boston Scientific Corp. and CryoCor Inc. said they entered a deal to co-develop therapies for atrial fibrillation -- abnormal beating of the heart's upper chambers. CryoCor's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results